Nephro Care India IPO is a book built issue of Rs 41.26 crores. The issue is entirely a fresh issue of 45.84 lakh shares.

Nephro Care India IPO opens for subscription on June 28, 2024 and closes on July 2, 2024. The allotment for the Nephro Care India IPO is expected to be finalized on Wednesday, July 3, 2024. Nephro Care India IPO will list on NSE SME with tentative listing date fixed as Friday, July 5, 2024.

Nephro Care India IPO price band is set at ₹85 to ₹90 per share. The minimum lot size for an application is 1600 Shares. The minimum amount of investment required by retail investors is ₹144,000. The minimum lot size investment for HNI is 2 lots (3,200 shares) amounting to ₹288,000.

Corporate Capitalventures Pvt Ltd is the book running lead manager of the Nephro Care India IPO, while Bigshare Services Pvt Ltd is the registrar for the issue. The market maker for Nephro Care India IPO is Ss Corporate Securities.

Refer to Nephro Care India IPO RHP for detailed information.

Nephro Care India IPO Details

IPO Date June 28, 2024 to July 2, 2024
Listing Date [.]
Face Value ₹10 per share
Price Band ₹85 to ₹90 per share
Lot Size 1600 Shares
Total Issue Size 4,584,000 shares
(aggregating up to ₹41.26 Cr)
Fresh Issue 4,584,000 shares
(aggregating up to ₹41.26 Cr)
Issue Type Book Built Issue IPO
Listing At NSE SME
Share holding pre issue 11,902,400
Share holding post issue 16,486,400
Market Maker portion 230,400 shares
Ss Corporate Securities

Nephro Care India IPO Reservation

Nephro Care India IPO offers 4,584,000 shares. 825,600 (18.01%) to QIB, 619,200 (13.51%) to NII, 1,444,800 (31.52%) to RII and 1,238,400 (27.02%) to Anchor investors.

Investor Category Shares Offered
Anchor Investor Shares Offered 1,238,400 (27.02%)
Market Maker Shares Offered 230,400 (5.03%)
QIB Shares Offered 825,600 (18.01%)
NII (HNI) Shares Offered 619,200 (13.51%)
Retail Shares Offered 1,444,800 (31.52%)
Total Shares Offered 4,584,000 (100%)

Nephro Care India IPO Anchor Investors Details

Nephro Care India IPO raises Rs 11.15 crore from anchor investors. Nephro Care India IPO Anchor bid date is June 27, 2024. Nephro Care India IPO Anchor Investors list

Bid Date June 27, 2024
Shares Offered 1,238,400
Anchor Portion Size (In Cr.) 11.15
Anchor lock-in period end date for 50% shares (30 Days) August 2, 2024
Anchor lock-in period end date for remaining shares (90 Days) October 1, 2024

Nephro Care India IPO Timeline (Tentative Schedule)

Nephro Care India IPO opens on June 28, 2024, and closes on July 2, 2024.

IPO Open Date Friday, June 28, 2024
IPO Close Date Tuesday, July 2, 2024
Basis of Allotment Wednesday, July 3, 2024
Initiation of Refunds Thursday, July 4, 2024
Credit of Shares to Demat Thursday, July 4, 2024
Listing Date Friday, July 5, 2024
Cut-off time for UPI mandate confirmation 5 PM on July 2, 2024

Nephro Care India IPO Lot Size

Investors can bid for a minimum of 1600 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.

Application Lots Shares Amount
Retail (Min) 1 1600 ₹144,000
Retail (Max) 1 1600 ₹144,000
HNI (Min) 2 3,200 ₹288,000
Lot Size Calculator

Nephro Care India IPO Promoter Holding

The company promoter is Dr. Pratim Sengupta.

Share Holding Pre Issue 85.02%
Share Holding Post Issue 61.39%

About Nephro Care India Limited

Incorporated in 2014, Nephro Care India Limited is a comprehensive treatment center located in Kolkata, offering a wide range of clinical and lifestyle solutions, as well as renal insufficiency treatment for patients.

Nephro Care is supported by expert doctors, experienced paramedical professionals, and a skilled management team.

Currently, the hospital provides healthcare services to approximately 900 Chronic Kidney Disease patients every month. The hospital has 5 permanent doctors, 10 visiting consultants, and 70 experienced paramedical professionals. These services are delivered from its main Salt Lake clinic, which covers an area of 5,352 square feet, and three satellite clinics located in Salt Lake (HB 113) and Chandannagar, West Bengal.

At present, Nephro Care offers the following services at its clinics:

  • In-house Dialysis Unit
  • Outpatient Services in areas of Nephrology, Diabetology, Cardiology, Ophthalmology and Neurology
  • NABL accredited inhouse Pathology
  • Inhouse Pharmacy
  • Advance diagnostic facilities
  • Renal Nutrition department
  • Home Care
  • Mukti (Lifestyle Support Program)
  • Home Dialysis

As of March 31, 2024 the hospital employs 110 people in various departments.

 

Nephro Care India Limited Financial Information (Restated)

Nephro Care India Limited’s revenue increased by 398.84% and profit after tax (PAT) rose by 19920.41% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended 31 Dec 2023 31 Mar 2023 31 Mar 2022 31 Mar 2021
Assets 2,029.85 831.11 462.93 112.84
Revenue 1,989.60 1,709.51 342.70 183.26
Profit After Tax 340.04 194.24 -0.98 8.87
Net Worth 1,392.32 243.76 49.52 1.50
Reserves and Surplus 1,332.81 193.76 -0.48 0.50
Total Borrowing   246.39 253.74 69.27
Amount in ₹ Lakhs

Key Performance Indicator

The market capitalization of Nephro Care India IPO is Rs 148.38 Cr.

KPI as of December 31, 2023.

KPI Values
ROE 41.57%
ROCE 36.56%
RoNW 24.42%
P/BV 8.04
PAT Margin (%) 17.22

Check Nephro Care India IPO Peer Comparison here.

  Pre IPO Post IPO
EPS (Rs)  1.63 2.75
P/E (x)  55.15 32.73

Note:

  • The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2023 that is available in RHP.
  • The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of December 31, 2023 that is available in RHP.

Objects of the Issue (Nephro Care India IPO Objectives)

The company intends to utilize the Net Fresh Issue Proceeds for the following Objects

  1. Setting up of Multi Speciality Hospital in the name of “Vivacity Multi Specialty Hospital” (unit of Nephro Care) at Kolkata (Madhyamgaram), West Bengal; and
  2. General Corporate Expenses

Nephro Care India IPO Review (Avoid)

[Dilip Davda]  The company is engaged in providing healthcare services with renal insufficiency treatment. It marked inconsistency in its net earnings for the reported periods and the sudden surge in bottom in for 9M-FY24 raise eyebrows and concern over its sustainability going forward. Based on its super annualized FY24 earnings, the issue appears aggressively priced. There is no harm in skipping this pricey bet. Read detail review…


Nephro Care India IPO Subscription Status (Bidding Detail)

The Nephro Care India IPO is subscribed 9.33 times on June 28, 2024 2:57:57 PM (Day 1). The public issue subscribed 17.08 times in the retail category, 0.00 times in the QIB category, and 7.06 times in the NII category. Check Day by Day Subscription Details (Live Status) Reload Subscription

Category Subscription (times) Shares Offered Shares bid for
QIB 0.00 8,25,600 0
NII* 7.06 6,19,200 43,71,200
Retail 17.08 14,44,800 2,46,83,200
Total 9.33 31,15,200 2,90,54,400

Total Application : 15,427

*Market Maker portion is not included to NII/HNI.

Nephro Care India IPO Prospectus

Nephro Care India Limited Contact Details

Nephro Care India Limited
Flat No-1JC-18, 5th Floor Sec-III
Salt lake Kolkata, Bidhan Nagar Sai Complex,
North 24 Parganas -700098
Phone: +91 8017010197
Email: cs@nephrocareindia.com/
Websitehttps://www.nephrocareindia.com/

Nephro Care India IPO Registrar

Bigshare Services Pvt Ltd

Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Websitehttps://ipo.bigshareonline.com/ipo_status.html